Skip to content

The BGCS website uses cookies to give you the best possible experience. By continuing, we will assume you are happy to receive all cookies on the website. More information on cookies can be found on our privacy page.

NICE

The National Institute for Health and Clinical Excellence produces evidence based guidance and advice to improve outcomes for people using the NHS and other public health and social care services. Here are links to the most recent NICE guidance relevant to the management of gynaecological cancers.

Also they have updated the guidance on ovarian cancer recently and this is now published and here is the link and a sentence about it: Ovarian cancer This guidance covers the recognition and management of ovarian cancer.

Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer

Olaparib for maintenance treatment of relapsed, platinum-sensitive, BRCA mutation-positive ovarian, fallopian tube and peritoneal cancer after response to second-line or subsequent platinum-based chemotherapy